Lifecore Biomedical Inc (LFCR)

개요 뉴스 가격 이력 옵션 체인 Financials 토론 예측

Relative Volume:

Lifecore Biomedical Inc Stock (LFCR) Company Profile

Lifecore Biomedical Inc

Healthcare (1074)

(952) 368-4300

3515 LYMAN BOULEVARD, CHASKA

최신 SEC 제출 서류

LFCR's Discussions on Twitter

Compare LFCR vs TAK, TEVA, HLN, ZTS, UTHR

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
LFCR Lifecore Biomedical Inc	4.40	171.10M	147.12M	-33.88M	-13.62M	-0.4805
TAK Takeda Pharmaceutical Co Adr	18.45	57.90B	29.91B	1.30B	3.49B	0.4056
TEVA Teva Pharmaceutical Industries Ltd Adr	36.36	42.89B	17.53B	1.58B	444.18M	1.3457
HLN Haleon Plc Adr	9.60	43.41B	14.54B	2.22B	2.58B	0.4871
ZTS Zoetis Inc	75.81	31.00B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	487.61	22.35B	3.17B	1.29B	1.01B	27.09

Lifecore Biomedical Inc Stock (LFCR) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2026-03-17	업그레이드	Barrington Research	Mkt Perform → Outperform
2025-09-04	개시	KeyBanc Capital Markets	Sector Weight
2025-05-21	개시	William Blair	Outperform
2024-09-05	개시	Craig Hallum	Buy
2024-08-28	다운그레이드	Barrington Research	Outperform → Mkt Perform
2023-03-20	다운그레이드	Stephens	Overweight → Equal-Weight

Lifecore Biomedical Inc 주식(LFCR)의 최신 뉴스

Lifecore Biomedical Inc (LFCR) 재무 분석

Lifecore Biomedical Inc (LFCR)

Lifecore Biomedical Inc Stock (LFCR) Company Profile

Compare LFCR vs TAK, TEVA, HLN, ZTS, UTHR

Lifecore Biomedical Inc Stock (LFCR) Upgrades & Downgrades

Lifecore Biomedical Inc 주식(LFCR)의 최신 뉴스

Lifecore Biomedical Earnings Call Balances Growth and Strain - TipRanks

Lifecore (LFCR) Quarterly Scorecard: EPS Beats Its Estimate; The Stock Records a 1.83% Increase on the DayROA Comparison - vinanet.vn

Lifecore Biomedical (LFCR) Q2 2026 Earnings Call Transcript - AOL.com

Core Thesis Behind Lifecore Biomedical (LFCR): Monetizing Excess Capacity - Yahoo Finance

Avoiding Lag: Real-Time Signals in (LFCR) Movement - Stock Traders Daily

LFCR Q2 2026 Earnings: Narrower-Than-Expected Loss Delivers 16.59% EPS SurpriseAnalyst Coverage Count - vinanet.vn

Lifecore Biomedical (LFCR) Holds Above $4.50 Support as Shares Edge LowerSell Signal Alerts - Vinanet

LFCR Q2 2026 Earnings: Narrower-than-Expected Loss Offers Modest EncouragementGuidance vs Actual - vinanet.vn

Judge approves $3.75 million Lifecore investor settlement - Minnesota Lawyer

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lifecore - TMX Newsfile

Lifecore Biomedical Reports Financial Results for the Second Quarter Ended June 30, 2026, and Provides Corporate Update - marketscreener.com

Lifecore Biomedical, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance

Discipline and Rules-Based Execution in LFCR Response - Stock Traders Daily

Earnings call transcript: Lifecore Biomedical tops revenue view in Q2 2026 - Investing.com Canada

Lifecore Biomedical (NASDAQ:LFCR) Releases Quarterly Earnings Results, Beats Estimates By $0.03 EPS - MarketBeat

Transcript : Lifecore Biomedical, Inc., Q2 2026 Earnings Call, Aug 05, 2026 - marketscreener.com

Lifecore Biomedical, Inc. Reaffirms Earnings Guidance for the Calendar Year 2026 - marketscreener.com

LFCR: Revenue and profit declined, but cost cuts and new wins support strong long-term growth outlook - TradingView

Lifecore Biomedical, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView

Lifecore Biomedical Q2 Earnings Call Highlights - MarketBeat

Lifecore Biomedical, Inc. (LFCR) Q2 FY2026 earnings call transcript - Yahoo Finance

LFCR: Q2 revenue fell 6.2% to $34.2M, but new business wins and guidance reaffirmed - tradingview.com

Lifecore Biomedical Backs 2026 Adj EBITDA of $20.5M-$25M >LFCR - Moomoo

Lifecore Biomedical Q2 revenue falls to $34.2 million as loss widens - Quiver Quantitative

Lifecore Biomedical 2026: Revenue $34.17M, EPS ($0.19) — 10-Q Summary - TradingView

Lifecore Biomedical: Q2 Earnings Snapshot - marketscreener.com

Lifecore Biomedical (NASDAQ: LFCR) Q2 revenue slips as 2026 guidance reaffirmed - Stock Titan

Lifecore Biomedical Reports Financial Results for the - GlobeNewswire

LFCR: Q2 2026 delivered strong revenue, margin expansion, and robust pipeline growth - TradingView

Lifecore Biomedical Q2 FY26 net loss widens to $6.2 million; revenue falls 6.2% to $34.2 million - Bitget

Lifecore Biomedical Inc expected to post a loss of 22 cents a shareEarnings Preview - TradingView

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lifecore - TMX Newsfile

SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lifecore - TMX Newsfile

LFCR Q1 2026 Earnings: Wider-than-Expected Loss Overshadows the QuarterDiluted EPS Report - Vinanet

Zacks Research Upgrades Lifecore Biomedical (NASDAQ:LFCR) to Hold - MarketBeat

Lifecore Biomedical to Report Financial Results for the Second Quarter Ended June 30, 2026, on August 5, 2026 - GlobeNewswire

LFCR Q1 2026 Earnings: Significant Earnings Miss Amid Operational ChallengesPretax Income Report - vinanet.vn

Lifecore Biomedical (LFCR) Tests Resistance After a Modest UptickBull Flag - dars.gov.et

Lifecore Biomedical signs three new customer de... - Pluang

Lifecore Biomedical Signs Three New Customer Agreements - The Manila Times

Lifecore Biomedical Announces Three New Customer Agreements Spanning Late-Stage Regenerative Medicine and Early-Stage Development Programs - Quiver Quantitative

Lifecore Biomedical Inc (LFCR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Lifecore Biomedical Inc (LFCR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Lifecore Biomedical Inc (LFCR) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

LFCR|Lifecore Biomedical Inc|Price:4.330|Chg%:-0.100 - TradingKey

Lifecore Biomedical Inc (LFCR) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Lifecore Biomedical (LFCR) Faces Selling Pressure as Stock Tests Key SupportIchimoku Cloud - dars.gov.et

Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical - The National Law Review

Lifecore Biomedical, Inc. Revenue Breakdown – NASDAQ:LFCR - TradingView

LFCR Q1 2026 Earnings: Deep EPS Miss Undermines Sentiment as Revenue Remains UndisclosedGuidance Revision Trend - vinanet.vn

Lifecore Biomedical Inc. (LFCR) Q1 2026 Earnings: EPS Misses Estimates by Wide Margin Amid Operational ChallengesBook Value Growth - dars.gov.et

Lifecore Biomedical Inc (LFCR) 재무 분석

매출

순이익

현금흐름

주당 순 이익

LFCR과 유사한 종목